Released Apr 30, 2015, after the close
10-Q filed May 1, 2015, 31 days after period end · 0000917520-15-000022
Q1 2015 · 10-Q
Revenue$202.53M$202.53M −5.8% vs Q1 2014−7.5% vs Q4 2014
Net Income$8.38M$8.38M +280.1% vs Q1 2014−51.2% vs Q4 2014
EPS Diluted$0.13$0.13 +85.7% vs Q1 2014−75.0% vs Q4 2014
Gross Profit$127,313,000+13.1%
Operating Income$21,240,000+143.1%
Operating Cash Flow$31,619,000+181.0%
Free Cash Flowderived$26,289,000N/M
Margins · derived
Gross margin62.9%+10.5 pt vs Q1 2014
Operating margin10.5%+6.4 pt vs Q1 2014
Net margin4.1%+3.1 pt vs Q1 2014
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2015 | Q1 2014 | Q1 2013 | Q1 2012 |
|---|---|---|---|---|
| Revenue | $202.53M | $215.06M | $196.65M | $196.19M |
| Net Income | $8.38M | $2.21M | -$6.03M | $6.69M |
| EPS Diluted | $0.13 | $0.07 | -$0.22 | $0.23 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Integra Lifesciences Holdings Corp · CIK 917520 · Engraved from SEC EDGAR